Healthcare -
Biotechnology - NASDAQ - US
$ 1.81
2.84 %
$ 1.15 B
Market Cap
-6.7
P/E
GERN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities GERN - Geron Corporation
-180 M
LAST VALUE
-87.25%
2 YEAR CAGR
-18.33%
5 YEAR CAGR
-25.33%
10 YEAR CAGR